MBAICheck-Cap Ltd. Ordinary Share

NAS · US · Healthcare · Diagnostics & Research · check-cap.com

8.040USDMkt Cap: 11.06M $P/E: 1.743d ago

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isf…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap11.06M $

Enterprise Value7.87M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)4.14M $

Revenue/Share—

Last Price8.040 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)1.74

P/E (Forward)—

PEG—

EV/EBITDA-3.56

EV/Revenue—

P/S—

P/B16.37

EPS (TTM)4.62

EPS (Forward)—

52W Range

8.0306% of range8.210

52W High8.210 USD

52W Low8.030 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE120.45%

ROA55.30%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-46.00K $

CapEx (TTM)—

FCF Margin—

FCF Yield7.66%

Net Debt-203.00K $

Net Debt/EBITDA0.09

Balance Sheet

Debt/Equity0.00

Current Ratio0.05

Quick Ratio0.05

Book Value/Sh0.4900 USD

Cash/Share0.2180 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:7

Split DateAug 13, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.35M

Float813.34K

Insiders27.80%

Institutions0.84%

Short Interest

Short Ratio2.0d

Short % Float1.65%

Short % Out.1.24%

Shares Short13.67K

Short (prev mo.)12.49K

Technical

SMA 508.421 (-4.5%)

SMA 20010.94 (-26.5%)

Beta0.82

S&P 52W Chg21.00%

Avg Vol (30d)4.40K

Avg Vol (10d)28.40K

Technical Indicators

RSI (14)56.7

MACD1.6666

MACD Signal1.4504

MACD Hist.+0.2162

BB Upper12.69 USD

BB Middle5.165 USD

BB Lower-2.3578 USD

BB Width291.31%

ATR (14)1.828 USD

Vol Ratio (20d)0.11x